NCT06939933

Brief Summary

Sickle cell anemia is a global public health disorder that affects millions of people across the globe. It is an inherited autosomal recessive hemoglobin condition caused by a beta-globin gene mutation that results in an aberrant sickle cell hemoglobin molecule with glutamic acid replaced by valine at position six of the beta-globin chain. Sickle cell anemia is a hereditary illness characterized by persistent microvascular blockage by sickle-shaped cells, chronic hemolytic anemia, and tissue destruction. Red-cell dehydration, hypoxemia, metabolic acidosis, and hyperthermia are typical vaso-occlusive triggers. Children with sickle cell anemia frequently have poor growth and nutritional status, increased protein turnover, decreased lean body mass, and elevated resting and lower activity energy expenditures. These clinical findings present a problem for recommending exercise when taken as a whole, while engaging in physical activity increases the chance of issues like a "painful episode,". Children with sickle cell anemia miss out on the favorable health effects of regular physical activity, such as the growth of lean body mass, strength, and fitness. Vaso-occlusive events are recurring and prevalent in sickle cell anemia-related morbidity. Patients also have a higher chance of developing central nervous system conditions such cerebral vasculopathy and overt and covert stroke. It has been noted that the pathophysiological symptoms of SCA decrease skeletal muscle function. In fact, it has been demonstrated that individuals with SCA have diminished forearm and respiratory muscular maximal strength as well as peak locomotory muscle power. Vaso-occlusion, chronic hemolytic anemia, and vasculopathy form the core of sickle cell anemia pathophysiology and result in both acute and chronic consequences that have a significant negative influence on quality of life QoL. Even though clinical care for children with SCA has significantly improved in developed countries over the past few decades, children and adolescents with SCA still have a lower quality of life than their peers due to painful vaso-occlusive crises, frequent hospital admissions, and lengthy hospital stays. Generic and disease-specific measures of quality of life have been developed and validated in chronic illnesses to evaluate the influence of health on functional domains such physical and mental well-being, exhaustion, pain, social engagement, relationships, and emotional distress. Examples include the Child Health Questionnaire, Pediatric Quality of Life Sickle Cell Disease Module PedsQL SCD, and Patient-Reported Outcomes Measurement Information System PROMIS, all of which have been used to study SCA and have revealed various degrees of quality-of-life impairment, primarily in the United States. Health-related quality of life refers to the patient's assessment of how his or her well-being and level of functioning, in comparison to the perceived ideal, are influenced by personal health. A health-related quality of life assessment often considers physical, social, and emotional functioning in addition to academic and occupational performance. Studies on the quality of life for people with SCA have significantly risen during the previous five years. Measurement of health-related quality of life is beneficial for many reasons. Health-related quality of life can be used to measure the efficacy and effectiveness of treatment interventions, to predict outcomes and resource use, and to direct therapy. More importantly, the measurement of health-related quality of life aids in understanding the burden of disease that patients experience.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 23, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

January 6, 2026

Status Verified

January 1, 2026

Enrollment Period

29 days

First QC Date

April 9, 2025

Last Update Submit

January 2, 2026

Conditions

Keywords

aquatic exercisessickle cell anemiarehabilitationquality of lifemuscle powerchildren

Outcome Measures

Primary Outcomes (5)

  • assessing hand grip strength

    Hand-held dynamometer for assessing hand grip strength

    3 months

  • assess weight

    The Calibrated floor Health scale was used to assess weight

    3 months

  • assessing Lower limb, trunk muscles strength.

    3- Lafayette dynamometer for assessing Lower limb and trunk muscles strength.

    3 months

  • determine the child's standing height in centimeters (cm).

    The calibrated floor health scale was used to determine the child's standing height in centimeters (cm).

    3 months

  • assessing Health related quality of life

    4- Pediatric quality of life inventory 3.0 generic for assessing Health related quality of life

    3 months

Study Arms (2)

group (A)

EXPERIMENTAL

aquatic exercised in addition to the designed physical

Other: aquatic exercise in addition to physical exercise

group (B)

EXPERIMENTAL

designed physical therapy program only

Genetic: designed physical exercises only

Interventions

Aquatic exercise refers to the use of water that facilitates the application of established therapeutic interventions, including stretching, strengthening, joint mobilization, balance and gait training and endurance training. Water has been throughout history for a variety of purposes including ; physical therapy, rehabilitation and sport. There activities are made possible by water's special qualities and the influence of these attributes on humans. Hydrotherapy is one of the most popular forms of complementary therapies that help in the treatment of children with disabilities. It is known to provide an opportunity to the children to do easier exercise. It also improves . Physical therapy and tailored exercise programs can help improve muscle strength, endurance, and overall physical function in children with SCA. Such programs need to be carefully designed to avoid triggering pain crises while promoting physical health and improving quality of life.

group (A)

Physical therapy and tailored exercise programs can help improve muscle strength, endurance, and overall physical function in children with SCA. Such programs need to be carefully designed to avoid triggering pain crises while promoting physical health and improving quality of life (Ballas et al., 2010). benefit from anaerobic activity patterns (Dougherty et al., 2018). A study to examine maximal muscle strength and peak power in children with sickle cell anemia found that maximal muscle strength and peak power are significantly less in children with sickle cell anemia compared to the control group

group (B)

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The children are assigned aged from 6-10 years.
  • Both genders were included.
  • They were able to follow instructions and understand commands.
  • Children were free from orthopedic deformities in the upper and lower limbs.
  • Children were not practicing any kind of sports.
  • Children must have a normal body mass index (BMI) in relation to their ages.

You may not qualify if:

  • Children with neurological, musculoskeletal, and cardiopulmonary diseases limit their movement.
  • Children with cognitive disorders.
  • Children suffering from auditory impairment that limit him or her from answering the questions.
  • Children with vaso occlusive crises.
  • Children who have another disease associated with SCA.
  • Children who had recent blood transfusion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eman samir shaltout

Tanta, Egypt

Location

MeSH Terms

Conditions

Anemia, Sickle Cell

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Intervention study model Parallel assignment The study will include 50 spastic children suffering from sickle cell anemia ( age 6 to 10 years and divided into 2 randomized subgroups. Group (A): Will receive aquatic exercised in addition to the designed physical Physical program : Group (B): Will receive the designed physical therapy program only.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
eman samir shaltout

Study Record Dates

First Submitted

April 9, 2025

First Posted

April 23, 2025

Study Start

November 1, 2025

Primary Completion

November 30, 2025

Study Completion

December 30, 2025

Last Updated

January 6, 2026

Record last verified: 2026-01

Locations